Breadcrumb AMCP.org Resource Center Topics Biosimilars AMCP Submits Comments to USP on Proposed Section 2.20 General Notices Tweet this pagePost this page on FacebookPost this page on LinkedInEmail this pagePrint this page 3/30/18 AMCP Submits Comments to USP on Proposed Section 2.20 General Notices AMCP Submits Comments to USP on Proposed Section 2.20 General Notices.pdf Tags: Biosimilars (52) Tweet this pagePost this page on FacebookPost this page on LinkedInEmail this pagePrint this page